The Expression of ARMCX1 in Gastric Cancer Contributes to Prognosis and Influences Chemotherapy.
Journal of immunology research(2023)
摘要
The altered expression of in patients with gastric cancer has been reported frequently, yet its correlation to prognosis and chemotherapy needs to be unveiled. In combination of the gene expression data retrieved from TCGA database and bioinformatic analysis, this study discovered 590 differentially expressed genes in the cancerous biopsies isolated from gastric patients, compared with controls. Among which, exhibited great potential to serve as a prognostic biomarker for gastric patients; furthermore, patients with low expression of could be more sensitive to these 9 chemotherapeutic agents: A-770041, AMG-706, ATRA, BEZ235, bortezomib, CGP60474, dasatinib, HG-64-1, and pazopanib, rather than the other chemotherapeutic agents. This study helps the improvement of evaluating the prognosis of gastric cancer patients, and would help optimize chemotherapeutic strategies in consideration of the expression of .
更多查看译文
关键词
gastric cancer contributes,gastric cancer,armcx1,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要